Respiratory syncytial virus, infants, nirsevimab, immunisation, public health
MIS-C, SARS-CoV-2, COVID-19, epidemiology, child
MIS-C, SARS-CoV-2, COVID-19, child, epidemiology
Residential relocation, environmental exposures, electronic health records, natural experiments.